Sensorineural Hearing Loss, BilateralNCT04777565
Study of a Minimally Invasive Cochlear Access for Cochlear Implantation Via a Robotic Procedure
A study testing Robotic surgery in people with Sensorineural Hearing Loss, Bilateral, run by MED-EL Elektromedizinische Geräte GmbH at 1 site in France.
Trial summary
The objectives of this study are to explore the efficacy and safety of a robotic procedure for a minimally invasive cochlear implantation. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Sensorineural Hearing Loss, Bilateral
- What is being tested?
- Robotic surgery
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 10 participants
- Where
- 1 siteFrance
- Study dates
- 15 Sep 2021to 1 Jan 2023
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Subjects scheduled for CI surgery according to clinical routine
- Subjects who will receive a cochlear implant of the MED-EL portfolio
- Signed and dated informed consent form
Who cannot join
- Lack of compliance with any inclusion criteria
- Age under 18 years
- Pregnancy
- Distance of the planned trajectory to the facial nerve is < 0.4 mm as per screening CT scan
- Distance of the planned trajectory to the chorda tympani is < 0.3 mm as per screening CT scan
- A safe inner ear access cannot be planned for preservation of RW membrane and cochlear structures
- Individuals where image guidance or robotic procedures are not indicated
- Individuals who have known allergy to components of the cochlear implant
Trial locations and contacts
1 site in 1 country.
About this study
Official title: The Efficacy of a Minimally Invasive Direct Cochlear Access Via the HEARO Procedure
The objectives of this study are to explore the efficacy and safety of a robotic procedure for a minimally invasive cochlear implantation.
Read the detailed description
The cochlear implant (CI) is a neural prothesis and has been the gold standard treatment for severe to profound sensorineural hearing loss over several decades. The surgical procedure for cochlear implantation surgery aims to atraumatically insert the electrode array of the cochlear implant into the cochlea. However, due to the location of the cochlea inside the skull, the surgeon is required to initially create an access from the surface of the temporal bone to the cochlea (inner ear). In conventional methods, this access is acquired by removal of large portions of the mastoid bone through a wide mastoidectomy and posterior tympanotomy. The outcome and success of the conventional procedure varies due to mainly two factors: surgeon skill and subject anatomical variation.
To overcome these variables toward a more consistent and less invasive cochlear implantation surgery, the development of robotic and image guided cochlear implantation has taken place.
This study primarily aims to explore the efficacy of the HEARO robotic cochlear implantation surgery.
Primary Objective
The primary objective of this study is to:
- explore the efficacy of a minimally invasive direct cochlear access via the HEARO procedure.
Secondary Objectives
The secondary objectives of this study are to:
- explore the safety of a minimally invasive direct cochlear access via the HEARO procedure.
- exploratively evaluate the electrode array insertion outcomes through the direct tunnel access.
- Conditions
- Sensorineural Hearing Loss, Bilateral
- Being tested
- Robotic surgery
- Keywords
- cochlear implant, robotic surgery, electrode insertion
- Medical subject headings
- Hearing Loss, Sensorineural
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Robotic surgeryOther
Cochlear implant surgery with HEARO procedure
| Study group | Role | What they receive |
|---|---|---|
| CI surgery | Experimental | cochlear implant surgery Receives: Other: Robotic surgery |
What is being measured
The primary outcome is the main question the study is designed to answer.
Electrode array insertion
- Relative ratio of successful electrode array insertions through the drilled direct cochlear access with the HEARO procedure to the total HEARO procedures (i.e. proportion of successful insertions with the procedure out of the total number of patients included in the study).
Measured: During surgery
Secondary outcomes (10)
Electrode array insertion outcome (efficacy)
- The angular insertion depth will be evaluated.
Measured: During surgery
Electrode array insertion outcome (efficacy)
- The number of contacts inserted will be evaluated.
Measured: During surgery
Electrode array insertion outcome (efficacy)
- The tip-fold over will be evaluated.
Measured: During surgery
Electrode array insertion outcome (efficacy)
- The scalar deviation will be evaluated.
Measured: During surgery
Insertion depth prediction accuracy (efficacy)
- The insertion depth prediction accuracy as the difference between the estimated insertion depth of the electrode at the planning and the actual insertion depth.
Measured: During surgery
Absolute angular accuracy of the drilled tunnel access (safety)
- The absolute lateral accuracy of the drilled tunnel to the facial nerve and chorda tympani is measured as the difference between the planned trajectory and the actual drilled trajectory distance.
Measured: During surgery
Absolute lateral accuracy of the drilled tunnel at the target (safety)
- The absolute lateral accuracy of the drilled tunnel is measured as the distance between the planned target trajectory position and actual target of the drilled trajectory position.
Measured: During surgery
Ratio of the round window membrane preservation during the inner ear access (safety)
- The ratio of the preserved round window (RW) membrane at the robotic inner ear access by visual inspection. This will be assessed as subjective evaluation by the surgeon.
Measured: During surgery
Timing of the HEARO procedure
- The timing of the different steps of the HEARO procedure will be recorded.
Measured: During surgery
Adverse events (safety)
- Adverse events will be recorded
Measured: During surgery
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted2 Mar 2021
- Study start15 Sep 2021
- Primary completion1 Jan 2023
- Study completion1 Jan 2023
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for Sensorineural Hearing Loss, BilateralStudies of the same condition, open and under way.
- More trials run by MED-EL Elektromedizinische Geräte GmbHThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Other
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 10 participants (actual)
Sponsor and investigators
- Lead sponsor
- MED-EL Elektromedizinische Geräte GmbH
- Sponsor type
- Industry (pharma, biotech, devices)
- Responsible party
- Sponsor
- Investigators
- Frédéric Venail, Pr, Principal investigator, University Hospital, Montpellier
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04777565
- Sponsor's protocol ID
- MED-EL_HEARO_french_study
- Status last verified
- Feb 2023
- First submitted
- 10 Feb 2021
- Last updated
- 21 Feb 2023
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Publications
Fourez AL, Kaderbay A, Villerabel C, Korchagina J, Pean V, Mondain M, Venail F. Implementation of Robot-Assisted Minimally Invasive Cochlear Implantation: A Feasibility Study. Otol Neurotol. 2025 Aug 1;46(7):809-815. doi: 10.1097/MAO.0000000000004531. Epub 2025 May 23.
PubMed 40423721
Study at a glance
From the registry record, last updated by the sponsor on 21 Feb 2023. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The Efficacy of a Minimally Invasive Direct Cochlear Access Via the HEARO Procedure
- ClinicalTrials.gov ID
- NCT04777565
- Acronym / sponsor ID
- MED-EL_HEARO_french_study
- Conditions
- Sensorineural Hearing Loss, Bilateral
- Keywords
- cochlear implant, robotic surgery, electrode insertion
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 10 participants (actual)
- Lead sponsor
- MED-EL Elektromedizinische Geräte GmbHIndustry (pharma, biotech, devices)
- Study start
- 15 Sep 2021 (actual)
- Primary completion
- 1 Jan 2023 (actual)
- Study completion
- 1 Jan 2023 (actual)
- First posted
- 2 Mar 2021 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The objectives of this study are to explore the efficacy and safety of a robotic procedure for a minimally invasive cochlear implantation.
Detailed description
The cochlear implant (CI) is a neural prothesis and has been the gold standard treatment for severe to profound sensorineural hearing loss over several decades. The surgical procedure for cochlear implantation surgery aims to atraumatically insert the electrode array of the cochlear implant into the cochlea. However, due to the location of the cochlea inside the skull, the surgeon is required to initially create an access from the surface of the temporal bone to the cochlea (inner ear). In conventional methods, this access is acquired by removal of large portions of the mastoid bone through a wide mastoidectomy and posterior tympanotomy. The outcome and success of the conventional procedure varies due to mainly two factors: surgeon skill and subject anatomical variation.
To overcome these variables toward a more consistent and less invasive cochlear implantation surgery, the development of robotic and image guided cochlear implantation has taken place.
This study primarily aims to explore the efficacy of the HEARO robotic cochlear implantation surgery.
Primary Objective
The primary objective of this study is to:
- explore the efficacy of a minimally invasive direct cochlear access via the HEARO procedure.
Secondary Objectives
The secondary objectives of this study are to:
- explore the safety of a minimally invasive direct cochlear access via the HEARO procedure.
- exploratively evaluate the electrode array insertion outcomes through the direct tunnel access.
Study design
- Primary purpose
- Other
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| CI surgery | Experimental | Other: Robotic surgerycochlear implant surgery |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (3 listed)
- Subjects scheduled for CI surgery according to clinical routine
- Subjects who will receive a cochlear implant of the MED-EL portfolio
- Signed and dated informed consent form
Key exclusion criteria (8 listed)
- Lack of compliance with any inclusion criteria
- Age under 18 years
- Pregnancy
- Distance of the planned trajectory to the facial nerve is < 0.4 mm as per screening CT scan
- Distance of the planned trajectory to the chorda tympani is < 0.3 mm as per screening CT scan
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Robotic surgeryCochlear implant surgery with HEARO procedure | Other | CI surgery |
Primary outcome
Electrode array insertion
Time frame: During surgery
• Relative ratio of successful electrode array insertions through the drilled direct cochlear access with the HEARO procedure to the total HEARO procedures (i.e. proportion of successful insertions with the procedure out of the total number of patients included in the study).
10 secondary outcomes
Electrode array insertion outcome (efficacy)
Time frame: During surgery
Electrode array insertion outcome (efficacy)
Time frame: During surgery
Electrode array insertion outcome (efficacy)
Time frame: During surgery
Electrode array insertion outcome (efficacy)
Time frame: During surgery
Insertion depth prediction accuracy (efficacy)
Time frame: During surgery
Absolute angular accuracy of the drilled tunnel access (safety)
Time frame: During surgery
Absolute lateral accuracy of the drilled tunnel at the target (safety)
Time frame: During surgery
Ratio of the round window membrane preservation during the inner ear access (safety)
Time frame: During surgery
Timing of the HEARO procedure
Time frame: During surgery
Adverse events (safety)
Time frame: During surgery
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 21 Feb 2023.
- Derived from this study: PubMed 40423721Fourez AL, Kaderbay A, Villerabel C, Korchagina J, Pean V, Mondain M, Venail F. Implementation of Robot-Assisted Minimally Invasive Cochlear Implantation: A Feasibility Study. Otol Neurotol. 2025 Aug 1;46(7):809-815. doi: 10.1097/MAO.0000000000004531. Epub 2025 May 23.
- Individual participant dataSharing planned: No
Related trials for Sensorineural Hearing Loss, Bilateral
Enrolling by invitationObservational study
Long Term Follow-up Study of AAVAnc80-hOTOF Gene Therapy
Otoferlin Gene-mediated Hearing Loss
Active, not recruiting
Performance of a Remote Microphone Compared to Hearing Aids Alone
Hearing Loss, Bilateral Sensorineural
Active, not recruiting
Clinical Utility of Residual Hearing in the Cochlear Implant Ear
Hearing Loss, Sensorineural, Hearing Loss
Active, not recruiting
A Pivotal Study to Evaluate the Clinical Benefit, Performance and Safety of a Totally Implantable Cochlear Implant (TICI) System in Adults
Hearing Loss, Bilateral Sensorineural
RecruitingPhase 3
Gene Therapy Trial for Otoferlin Gene-mediated Hearing Loss
Sensorineural Hearing Loss, Bilateral
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Frédéric Venail, Pr principal investigator
University Hospital, Montpellier
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Robotic surgery in people with Sensorineural Hearing Loss, Bilateral, run by MED-EL Elektromedizinische Geräte GmbH at 1 site in France.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 21 Feb 2023. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Electrode array insertion (time frame: During surgery). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT04777565, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Feb 2023.